NEW YORK (GenomeWeb) – Fulgent Genetics reported after the close of the market on Monday that its third quarter revenues declined 10 percent year over year.

For the three months ended September 30, the Temple City, California-based genetic testing firm reported revenues of $4.5 million compared to $5.0 million in the prior-year quarter, short of analysts' average estimate of $5.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.